ID: ALA5088603

Max Phase: Preclinical

Molecular Formula: C45H55FN12O7

Molecular Weight: 895.01

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)n1cnc2c(NCc3nc4cc(F)c(NCCCCCCCCCCNC(=O)COc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)cc4[nH]3)nc(N3CCOCC3)nc21

Standard InChI:  InChI=1S/C45H55FN12O7/c1-27(2)57-26-50-39-40(54-45(55-41(39)57)56-18-20-64-21-19-56)49-24-35-51-31-22-29(46)30(23-32(31)52-35)47-16-9-7-5-3-4-6-8-10-17-48-37(60)25-65-34-13-11-12-28-38(34)44(63)58(43(28)62)33-14-15-36(59)53-42(33)61/h11-13,22-23,26-27,33,47H,3-10,14-21,24-25H2,1-2H3,(H,48,60)(H,51,52)(H,49,54,55)(H,53,59,61)

Standard InChI Key:  NKPHVUBPIOSUEX-UHFFFAOYSA-N

Associated Targets(Human)

CDK12/Cyclin K 892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 895.01Molecular Weight (Monoisotopic): 894.4301AlogP: 5.00#Rotatable Bonds: 21
Polar Surface Area: 230.69Molecular Species: NEUTRALHBA: 15HBD: 5
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 5#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.50CX Basic pKa: 6.20CX LogP: 3.86CX LogD: 3.85
Aromatic Rings: 5Heavy Atoms: 65QED Weighted: 0.05Np Likeness Score: -1.19

References

1. Niu T, Li K, Jiang L, Zhou Z, Hong J, Chen X, Dong X, He Q, Cao J, Yang B, Zhu CL..  (2022)  Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor.,  228  [PMID:34864331] [10.1016/j.ejmech.2021.114012]

Source